4gso
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='4gso' size='340' side='right'caption='[[4gso]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='4gso' size='340' side='right'caption='[[4gso]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4gso]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4gso]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Bothrops_jararacussu Bothrops jararacussu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GSO OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GSO FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gso FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gso OCA], [https://pdbe.org/4gso PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gso RCSB], [https://www.ebi.ac.uk/pdbsum/4gso PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gso ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/VSP1_BOTJR VSP1_BOTJR] Thrombin-like enzyme that shows clotting activity upon human plasma. Shows specific fibrinogenolytic activity for Aalpha chain (FGA). Hydrolyzes fibrin, BAPNA and TAME, as well as chromogenic artificial substrates of the blood coagulation cascasde: S-27654 for factor X (F10), S-2302 for kallikrein (KLK), factor XIa (F11), and XIIa (F12), and S-2266 for kallikrein and factor XIa (F11). Subcutaneous injection into mice induces a mild edema. Intravenous and intramuscular injection reduce plasma fibrinogen concentration and increase the levels of fibrin(ogen) degradation products. Intramuscular injection also promotes an increase in the expression of proMMP-9, but is unable to activate it.<ref>PMID:17292935</ref> <ref>PMID:17466550</ref> <ref>PMID:17996740</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 23: | ||
[[Category: Bothrops jararacussu]] | [[Category: Bothrops jararacussu]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Arni | + | [[Category: Arni RK]] |
- | [[Category: Mariutti | + | [[Category: Mariutti R]] |
- | [[Category: Murakami | + | [[Category: Murakami MT]] |
- | [[Category: Sanata | + | [[Category: Sanata SV]] |
- | [[Category: Souza | + | [[Category: Souza TCAB]] |
- | [[Category: Ullah | + | [[Category: Ullah A]] |
- | [[Category: Zanphorlin | + | [[Category: Zanphorlin LM]] |
- | + | ||
- | + |
Revision as of 07:15, 26 October 2022
structure of Jararacussin-I
|